Literature DB >> 17764412

Cell membrane receptors on bovine mononuclear phagocytes involved in phagocytosis of Mycobacterium avium subsp paratuberculosis.

Cleverson D Souza1, Oral A Evanson, Srinand Sreevatsan, Douglas J Weiss.   

Abstract

OBJECTIVE: To determine cell membrane receptors involved in phagocytosis of Mycobacterium avium subsp paratuberculosis (MAP) organisms. SAMPLE POPULATION: Monocytes were obtained from healthy adult Holstein dairy cows that were test negative for MAP infection on the basis of bacteriologic culture of feces and serologic test results. PROCEDURES: Monocytes or bovine macrophage cell line (BoMac) cells were incubated with MAP organisms for 30, 60, or 120 minutes with or without inhibitors of integrins, CD14, or mannose receptors. Phagocytosis was evaluated by light microscopy or by flow cytometry. CD11a/CD18, CD11b, and CD14 expression on monocytes and BoMac cells was evaluated by use of flow cytometry.
RESULTS: Monocytes and BoMac cells rapidly phagocytized MAP organisms. However, compared with BoMac cells, monocytes had a greater total capacity to phagocytize MAP organisms. Addition of neutralizing anti-integrin antibodies (anti-CD11a/CD18 and anti-CD11b) substantially inhibited phagocytosis by monocytes during the first 60 minutes of incubation with MAP organisms, but were less effective at 120 minutes of incubation. Anti-CD11a/CD18 and anti-CD11b antibodies were less effective in inhibiting phagocytosis by BoMac cells. Addition of inhibitors of CD14 or mannose receptors also inhibited phagocytosis of MAP by monocytes. Addition of a combination of integrin and mannose inhibitors had an additive effect in reducing phagocytosis, but addition of integrin and CD14 inhibitors did not have an additive effect. CONCLUSIONS AND CLINICAL RELEVANCE: Multiple receptors are involved in phagocytosis of MAP organisms. Although CD11/CD18 receptors appear to be the major receptors used by MAP at early time points, mannose receptors and CD14 also contribute substantially to phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764412     DOI: 10.2460/ajvr.68.9.975

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Infection with Mycobacterium avium subsp. paratuberculosis results in rapid interleukin-1β release and macrophage transepithelial migration.

Authors:  Elise A Lamont; Scott M O'Grady; William C Davis; Torsten Eckstein; Srinand Sreevatsan
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  Uptake and persistence of Mycobacterium avium subsp. paratuberculosis in human monocytes.

Authors:  Dayle A Keown; David A Collings; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

3.  Mycobacterium avium subsp. paratuberculosis exploits miRNA expression to modulate lipid metabolism and macrophage polarisation pathways during infection.

Authors:  Kathryn Wright; Rachel Mizzi; Karren M Plain; Auriol C Purdie; Kumudika de Silva
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

4.  Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages.

Authors:  Harish K Janagama; Elise A Lamont; Sajan George; John P Bannantine; Wayne W Xu; Zheng J Tu; Scott J Wells; Jeremy Schefers; Srinand Sreevatsan
Journal:  BMC Genomics       Date:  2010-10-12       Impact factor: 3.969

5.  Antibodies Induced by Lipoarabinomannan in Bovines: Characterization and Effects on the Interaction between Mycobacterium Avium Subsp. Paratuberculosis and Macrophages In Vitro.

Authors:  Ana Jolly; Silvia Beatriz Colavecchia; Bárbara Fernández; Eloy Fernández; Silvia Leonor Mundo
Journal:  Vet Med Int       Date:  2011-06-08

6.  Mycobacterium avium subsp. paratuberculosis (Map) Fatty Acids Profile Is Strain-Dependent and Changes Upon Host Macrophages Infection.

Authors:  Marta Alonso-Hearn; Naiara Abendaño; Maria A Ruvira; Rosa Aznar; Mariana Landin; Ramon A Juste
Journal:  Front Cell Infect Microbiol       Date:  2017-03-21       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.